The Foundation for Sarcoidosis Research (FSR) has awarded $450,000 to three scientists to support research projects related to sarcoidosis diagnosis, treatment, and care. This funding comes through FSR’s Early Career Fellowship Grant, which is designed to provide scientists early in their career with resources for advancing sarcoidosis research.

“When did the pain start?” That’s a fairly straightforward question with an uncomplicated answer for most people: “I fell last Thursday and hurt my knee.” “I was helping a friend move over the weekend and tweaked my back.” “I ate something funky last night, and my stomach’s been hurting ever…

Sinonasal sarcoidosis, when the disease affects the nasal cavity and the surrounding air-filled cavities called the sinuses, mainly affects women and manifests as nasal obstruction, according to a review study. More than half of people with sinonasal sarcoidosis experience symptom lessening after treatment with medications and/or surgery. “Prompt…

The Foundation for Sarcoidosis Research (FSR) has launched an enhanced version of its patient registry, FSR-SARC, to help maximize the impact of patient participation in research. “Now in its tenth year, the Registry has been one of our most powerful tools to elevate patient voices in the advancement of…

Last week, my husband and I took a road trip to see the Yankees play the Reds in Cincinnati, checking another stadium off our bucket list. We went out for brunch before the game and had a nice chat with our waitress, mostly admiring each other’s tattoos. The food, our…

A new study from researchers in Turkey suggests that a ratio taking into account the amount of angiotensin-converting enzyme (ACE) and of lymphocytes, a type of white blood cell — a ratio elevated in patients with recurrent disease after stopping treatment — is a potential biomarker for people with…

This month, I watched the 78th annual Tony Awards, looking forward to performances from the year’s top shows. I’m always hoping to see my new favorites recognized and get ideas for what to attend next. This year’s awards show was extra special, featuring a reunion and medley from the original…

A Partner Grant from the Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) will support a research project focused on possible connections between air pollution and outcomes of people with sarcoidosis. The grant, totaling $100,000 over two years, was awarded to Mark Mallozzi, MD,…

The first participants in a Phase 2 clinical trial testing brepocitinib, Roivant’s experimental oral treatment, in adults with cutaneous sarcoidosis have been dosed, and top-line results are expected in the second half of 2026. The company had this year announced plans to launch this proof-of-concept trial, called BEACON…

Methotrexate appears to take longer to start acting, but is no less effective than the corticosteroid prednisone as a first-line treatment for pulmonary sarcoidosis, according to the early findings of an ongoing Phase 4 clinical trial. The researchers noted that, while methotrexate treatment is associated with a similar number…